Newsletter subscription & archive

AIS6 Aarhus Immunotherapy Symposium: New insights and unexplored opportunities of Immunotherapy

The annual Immunotherapy Symposium at Aarhus University Hospital takes place on 26 November from 13.00-20

In 2020 Biopeople once more supports the Aarhus Immunotherapy Symposium, which this time will be virtual.

Prepare for an exciting day with high level presentations. Confirmed speakers are: Solange Peters (CHUV); Stephen Durham (Imperial College); Malte Peters (Morphosys); Michael Ehrenstein (UCL); Stinne Greisen (AU); Mario Ehlers (Boehringer Ingelheim); and Adam Sander (AdaptVac)

When

26-11-2020 15:00 - 19:00

Organizer

Department of Biomedicine, Aarhus University

PROGRAM

3:00-4:00 pm CET

  • Solange Peters, Lausanne University, Lausanne, CH: “Promises and limitations of immunotherapy for lung cancer”
  • Malte Peters, Morphosys AG, Munich, DE: “Modern Drug Development Using Real World Data Approaches”

4:15-5:45 pm CET

  • Mario Ehlers, Boehringer Ingelheim, Ridgefield, US: “T cell exhaustion as a therapeutic strategy in autoimmunity”
  • Stinne Greisen, Aarhus University, Aarhus, DK: ”Co-inhibitory receptors in arthritic conditions - their relation to disease activity and tissue preservation”
  • Michael Ehrenstein, University College London, London, UK: ”Anti-TNF was the first regulatory T cell targeted therapy for rheumatoid arthritis”

6:00-7:00 pm CET

  • Adam Sander, AdaptVac, Copenhagen, DK: “Development of a COVID-19 vaccine based on virus-like particles displaying the SARS-CoV-2 receptor-binding domain”
  • Stephen Durham, Imperial College, London, UK: “New indications for allergen immunotherapy”

You are welcome to register now by following this link to registration

Contact: Rune Thomsen

Downloads

DownloadAIS6_FINAL_PROGRAM.pdf

Close
What are you looking for?